Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3755)
All Articles published online
|
Jul 28, 2009 (publication date) through May 21, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Khattab MA. Targeting host factors: A novel rationale for the management of hepatitis C virus. World J Gastroenterol 2009; 15(28): 3472-3479 [PMID: 19630100 DOI: 10.3748/wjg.15.3472] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v15/i28/3472.htm |
| Number | Citing Articles |
| 1 |
Oriana Tabarrini, Serena Massari, Violetta Cecchetti. 6-Desfluoroquinolones as HIV-1 Tat-Mediated Transcription Inhibitors. Future Medicinal Chemistry 2010; 2(7): 1161 doi: 10.4155/fmc.10.208
|
| 2 |
Syo Nakajima, Koichi Watashi, Hirofumi Ohashi, Shinji Kamisuki, Jesus Izaguirre-Carbonell, Andrew Tae-Jun Kwon, Harukazu Suzuki, Michiyo Kataoka, Senko Tsukuda, Maiko Okada, Meng Ling Moi, Toshifumi Takeuchi, Minetaro Arita, Ryosuke Suzuki, Hideki Aizaki, Takanobu Kato, Tadaki Suzuki, Hideki Hasegawa, Tomohiko Takasaki, Fumio Sugawara, Takaji Wakita, J.-H. J. Ou. Fungus-Derived Neoechinulin B as a Novel Antagonist of Liver X Receptor, Identified by Chemical Genetics Using a Hepatitis C Virus Cell Culture System. Journal of Virology 2016; 90(20): 9058 doi: 10.1128/JVI.00856-16
|
| 3 |
Meng-Hao Huang, Hu Li, Rong Xue, Jianrui Li, Lihua Wang, Junjun Cheng, Zhouyi Wu, Wenjing Li, Jinhua Chen, Xiaoqin Lv, Qiang Li, Pei Lan, Limin Zhao, Yongfeng Yang, Zonggen Peng, Jiandong Jiang. Up-regulation of glycolipid transfer protein by bicyclol causes spontaneous restriction of hepatitis C virus replication. Acta Pharmaceutica Sinica B 2019; 9(4): 769 doi: 10.1016/j.apsb.2019.01.013
|
| 4 |
Hu Li, Jia-Li Tan, Jian-Rui Li, Nan-Nan Liu, Jin-Hua Chen, Xiao-Qin Lv, Li-li Zou, Biao Dong, Zong-Gen Peng, Jian-Dong Jiang. A proof-of-concept study in HCV-infected Huh7.5 cells for shortening the duration of DAA-based triple treatment regimens. Biomedicine & Pharmacotherapy 2019; 116: 108976 doi: 10.1016/j.biopha.2019.108976
|
| 5 |
Boris Pastorino, Antoine Nougairède, Nathalie Wurtz, Ernest Gould, Xavier de Lamballerie. Role of host cell factors in flavivirus infection: Implications for pathogenesis and development of antiviral drugs. Antiviral Research 2010; 87(3): 281 doi: 10.1016/j.antiviral.2010.04.014
|
| 6 |
Takumi Kawaguchi, Eitaro Taniguchi, Minoru Itou, Masahiro Sakata, Shuji Sumie, Michio Sata. Insulin resistance and chronic liver disease. World Journal of Hepatology 2011; 3(5): 99-107 doi: 10.4254/wjh.v3.i5.99
|
| 7 |
Zongyi Hu, Xin Hu, Shanshan He, Hyung Joon Yim, Jingbo Xiao, Manju Swaroop, Cordelle Tanega, Ya-qin Zhang, Guanghui Yi, C. Cheng Kao, Juan Marugan, Marc Ferrer, Wei Zheng, Noel Southall, T. Jake Liang. Identification of novel anti-hepatitis C virus agents by a quantitative high throughput screen in a cell-based infection assay. Antiviral Research 2015; 124: 20 doi: 10.1016/j.antiviral.2015.10.018
|
| 8 |
Mahmoud Khattab, Mohammed Eslam, Mohammed Ahmed Sharwae, Mohammed Shatat, Ahmed Ali, Lamia Hamdy. Insulin Resistance Predicts Rapid Virologic Response to Peginterferon/Ribavirin Combination Therapy in Hepatitis C Genotype 4 Patients. American Journal of Gastroenterology 2010; 105(9): 1970 doi: 10.1038/ajg.2010.110
|
| 9 |
Julia Hillung, Elena Ruiz-López, Itxaso Bellón-Echeverría, Pilar Clemente-Casares, Antonio Mas. Characterization of the interaction between hepatitis C virus NS5B and the human oestrogen receptor alpha. Journal of General Virology 2012; 93(4): 780 doi: 10.1099/vir.0.039396-0
|
| 10 |
Oriana Tabarrini, Serena Massari, Luca Sancineto, Dirk Daelemans, Stefano Sabatini, Giuseppe Manfroni, Violetta Cecchetti, Christophe Pannecouque. Structural Investigation of the Naphthyridone Scaffold: Identification of a 1,6‐Naphthyridone Derivative with Potent and Selective Anti‐HIV Activity. ChemMedChem 2011; 6(7): 1249 doi: 10.1002/cmdc.201100073
|
| 11 |
C. M. Lange, C. Sarrazin, S. Zeuzem. Review article: specifically targeted anti‐viral therapy for hepatitis C – a new era in therapy. Alimentary Pharmacology & Therapeutics 2010; 32(1): 14 doi: 10.1111/j.1365-2036.2010.04317.x
|
| 12 |
Tianming Zhao, Lihong Mao, Zihan Yu, Yangyang Hui, Hongjuan Feng, Xiaoyu Wang, Lin Lin, Xiaofei Fan, Xin Chen, Bangmao Wang, Xiaocang Cao, Chao Sun. Therapeutic potential of bicyclol in liver diseases: Lessons from a synthetic drug based on herbal derivative in traditional Chinese medicine. International Immunopharmacology 2021; 91: 107308 doi: 10.1016/j.intimp.2020.107308
|
| 13 |
Dhritiman Dey, Adhiraj Dasgupta, Dipanjan Ghosh, Oindrila Bhattacharjee, Abhrajyoti Ghosh, Ayae Honda, Dhrubajyoti Chattopadhyay. Host proteins Alpha-2-Macroglobulin and LRP1 associate with Chandipura virus. Biochimie 2024; 218: 105 doi: 10.1016/j.biochi.2023.07.019
|
| 14 |
Muhammad Usman Ashraf, Kanzal Iman, Muhammad Farhan Khalid, Hafiz Muhammad Salman, Talha Shafi, Momal Rafi, Nida Javaid, Rashid Hussain, Fayyaz Ahmad, Syed Shahzad‐Ul‐Hussan, Shaper Mirza, Muhammad Shafiq, Samia Afzal, Sadia Hamera, Saima Anwar, Romena Qazi, Muhammad Idrees, Sohail A. Qureshi, Safee Ullah Chaudhary. Evolution of efficacious pangenotypic hepatitis C virus therapies. Medicinal Research Reviews 2019; 39(3): 1091 doi: 10.1002/med.21554
|
| 15 |
Mahmoud Aboelneen Khattab, Mohammed Eslam. The Impact of Host Factors on Management of Hepatitis C Virus. Hepatitis Monthly 2012; 12(4): 235 doi: 10.5812/hepatmon.5883
|
| 16 |
Sobia Kanwal, Tariq Mahmood. Hepatitis C virus resistance to interferon therapy: an alarming situation. Open Life Sciences 2014; 9(12): 1155 doi: 10.2478/s11535-014-0352-8
|
| 17 |
M. J. LaMarche, J. Borawski, A. Bose, C. Capacci-Daniel, R. Colvin, M. Dennehy, J. Ding, M. Dobler, J. Drumm, L. A. Gaither, J. Gao, X. Jiang, K. Lin, U. McKeever, X. Puyang, P. Raman, S. Thohan, R. Tommasi, K. Wagner, X. Xiong, T. Zabawa, S. Zhu, B. Wiedmann. Anti-Hepatitis C Virus Activity and Toxicity of Type III Phosphatidylinositol-4-Kinase Beta Inhibitors. Antimicrobial Agents and Chemotherapy 2012; 56(10): 5149 doi: 10.1128/AAC.00946-12
|
| 18 |
M. Carmen Roque‐Cuéllar, Berta Sánchez, José Raúl García‐Lozano, Antonio Garrido‐Serrano, Manuel Sayago, Juan Manuel Praena‐Fernández, Antonio Núñez‐Roldán, José Aguilar‐Reina. Expression of CD81, SR‐BI and LDLR in lymphocytes and monocytes from patients with classic and occult hepatitis C virus infection. Journal of Medical Virology 2012; 84(11): 1727 doi: 10.1002/jmv.23345
|
| 19 |
Yuan-Lung Cheng, Keng-Hsueh Lan, Wei-Ping Lee, Szu-Han Tseng, Li-Rong Hung, Han-Chieh Lin, Fa-Yauh Lee, Shou-Dong Lee, Keng-Hsin Lan. Amiodarone inhibits the entry and assembly steps of hepatitis C virus life cycle. Clinical Science 2013; 125(9): 439 doi: 10.1042/CS20120594
|
| 20 |
Eric Fleta-Soriano, Javier P Martinez, Bettina Hinkelmann, Klaus Gerth, Peter Washausen, Juana Diez, Ronald Frank, Florenz Sasse, Andreas Meyerhans. The myxobacterial metabolite ratjadone A inhibits HIV infection by blocking the Rev/CRM1-mediated nuclear export pathway. Microbial Cell Factories 2014; 13(1) doi: 10.1186/1475-2859-13-17
|
| 21 |
So-Young Kim, Hong Kim, Sang-Won Kim, Na-Rae Lee, Chae-Min Yi, Jinyuk Heo, Bum-Joon Kim, Nam-Jung Kim, Kyung-Soo Inn. An Effective Antiviral Approach Targeting Hepatitis B Virus with NJK14047, a Novel and Selective Biphenyl Amide p38 Mitogen-Activated Protein Kinase Inhibitor. Antimicrobial Agents and Chemotherapy 2017; 61(8) doi: 10.1128/AAC.00214-17
|
| 22 |
Ángela Vázquez-Calvo, Flavia Caridi, Mónica González-Magaldi, Juan-Carlos Saiz, Francisco Sobrino, Miguel A. Martín-Acebes. The Amino Acid Substitution Q65H in the 2C Protein of Swine Vesicular Disease Virus Confers Resistance to Golgi Disrupting Drugs. Frontiers in Microbiology 2016; 7 doi: 10.3389/fmicb.2016.00612
|
| 23 |
Matthew S Miller, Joe S Mymryk. An Unhealthy Relationship: Viral Manipulation of the Nuclear Receptor Superfamily. Future Microbiology 2011; 6(9): 999 doi: 10.2217/fmb.11.80
|
| 24 |
Neoechinulins: Molecular, cellular, and functional attributes as promising therapeutics against cancer and other human diseases. Biomedicine & Pharmacotherapy 2022; 145: 112378 doi: 10.1016/j.biopha.2021.112378
|
| 25 |
Jin-Ching Lee, Wei-Chun Chen, Shou-Fang Wu, Chin-kai Tseng, Ching-Yi Chiou, Fang-Rong Chang, Shih-hsien Hsu, Yang-Chang Wu. Anti-hepatitis C virus activity of Acacia confusa extract via suppressing cyclooxygenase-2. Antiviral Research 2011; 89(1): 35 doi: 10.1016/j.antiviral.2010.11.003
|
| 26 |
Soren Gantt, Eliora Gachelet, Jacquelyn Carlsson, Serge Barcy, Corey Casper, Michael Lagunoff. Nelfinavir Impairs Glycosylation of Herpes Simplex Virus 1 Envelope Proteins and Blocks Virus Maturation. Advances in Virology 2015; 2015: 1 doi: 10.1155/2015/687162
|
| 27 |
Matt Driedger, Chrissi Galanakis, Mary-Anne Doyle, Curtis L. Cooper. Direct-acting antiviral hepatitis C virus treatment perturbation of the metabolic milieu. European Journal of Gastroenterology & Hepatology 2019; 31(2): 260 doi: 10.1097/MEG.0000000000001292
|
| 28 |
M. Eslam, R. Aparcero, T. Kawaguchi, J. A. Del Campo, M. Sata, M. A. Khattab, M. Romero‐Gomez. Meta‐analysis: insulin resistance and sustained virological response in hepatitis C. Alimentary Pharmacology & Therapeutics 2011; 34(3): 297 doi: 10.1111/j.1365-2036.2011.04716.x
|
| 29 |
Abdel-Rahman El-Zayadi. HCV offensive mechanisms versus host’s defensive strategies. Arab Journal of Gastroenterology 2009; 10(4): 117 doi: 10.1016/j.ajg.2009.10.006
|
| 30 |
Ángela Vázquez-Calvo, Juan-Carlos Saiz, Francisco Sobrino, Miguel A. Martín-Acebes. Inhibition of Enveloped Virus Infection of Cultured Cells by Valproic Acid. Journal of Virology 2011; 85(3): 1267 doi: 10.1128/JVI.01717-10
|
| 31 |
Tamas Balla. Phosphoinositides: Tiny Lipids With Giant Impact on Cell Regulation. Physiological Reviews 2013; 93(3): 1019 doi: 10.1152/physrev.00028.2012
|
| 32 |
Jinhong Chang, Ju-Tao Guo, Yanming Du, Timothy Block. Imino sugar glucosidase inhibitors as broadly active anti-filovirus agents. Emerging Microbes & Infections 2013; 2(1): 1 doi: 10.1038/emi.2013.77
|
| 33 |
Florencia N. Linero, Claudia S. Sepúlveda, Federico Giovannoni, Viviana Castilla, Cybele C. García, Luis A. Scolaro, Elsa B. Damonte. Host Cell Factors as Antiviral Targets in Arenavirus Infection. Viruses 2012; 4(9): 1569 doi: 10.3390/v4091569
|
| 34 |
Lindsay Lundberg, Ashwini Brahms, Idris Hooper, Brian Carey, Shih-Chao Lin, Bibha Dahal, Aarthi Narayanan, Kylene Kehn-Hall. Repurposed FDA-Approved drug sorafenib reduces replication of Venezuelan equine encephalitis virus and other alphaviruses. Antiviral Research 2018; 157: 57 doi: 10.1016/j.antiviral.2018.07.005
|
| 35 |
Shuang Sun, Guojiang Jin, Hui Kang. CD81 and CLDN1 polymorphisms and hepatitis C virus infection susceptibility: A case–control study. Gene 2015; 567(1): 87 doi: 10.1016/j.gene.2015.04.072
|
| 36 |
Sang-Min Kang, Seri Lim, Seung-Jae Won, Ye-Jin Shin, Yun-Sook Lim, Byung-Yoon Ahn, Soon B. Hwang. c-Fos regulates hepatitis C virus propagation. FEBS Letters 2011; 585(20): 3236 doi: 10.1016/j.febslet.2011.08.041
|
| 37 |
Taher I. El Serafi, Mohamed M. Awad, Loaa A. Tag Eldeen, Ahmed T. El Serafi, Marwa Husin. Effect of interleukin-6 and insulin resistance on early virological response of Egyptian chronic hepatitis C patients to combined pegylated interferon plus ribavirin therapy. Egyptian Liver Journal 2013; 3(2): 21 doi: 10.1097/01.ELX.0000427103.05494.6c
|